3:20cv367 • January 16, 2020
Class Period Start
January 7, 2019
Class Period End
July 1, 2020
PSLRA Deadline
March 16, 2020
Case Allegations
10b5 + Sec11
10b-5 Statutes of Repose
Jan 7, 2022
Sec11 Statutes of Repose
Aug 7, 2022
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
February 13, 2023
Settlement Fund
$17,500,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that during the period from January 8, 2019, through and including February 28, 2020 (“Settlement Class Period”), you purchased or otherwise acquired common stock of Portola Pharmaceuticals, Inc. (“Portola Inc.” or the “Company”), including pursuant to the Company’s secondary public offering in August 2019.
Claim Administrator
Epiq
Portola Pharmaceuticals, Inc. Securities Litigation
c/o Epiq Class Action & Claims Solutions, Inc.
P.O. Box 6800
Portland, OR 97228-6800
+1 844-808-4889
[email protected]
Settlement Website
www.PortolaSecuritiesLitigation.comHearing Date
March 2, 2023
Opt-out Deadline
February 9, 2023
Settlement Note
Download hereProof Of Claim
Download here
Dec 15, 2023
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Mar 6, 2023
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Oct 31, 2022
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Oct 31, 2022
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Sep 19, 2022
Feb 17, 2022
Motion for Class Certification
The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.
Jan 20, 2022
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Sep 21, 2021
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Aug 31, 2021
A new complaint has been filed on behalf of certain investors in PORTOLA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Aug 10, 2021
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
May 5, 2021
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Apr 12, 2021
Mar 31, 2021
A new complaint has been filed on behalf of certain investors in PORTOLA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Mar 10, 2021
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Dec 15, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Dec 15, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Dec 15, 2020
Nov 5, 2020
A new complaint has been filed on behalf of certain investors in PORTOLA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Oct 29, 2020
Oct 22, 2020
Jul 1, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jun 15, 2020
May 20, 2020
A new complaint has been filed on behalf of certain investors in PORTOLA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Apr 22, 2020
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Feb 28, 2020
Another plaintiff has filed a complaint on behalf of investors in PORTOLA PHARMACEUTICALS INC. The allegations and class definitions are substantively the same.
Feb 24, 2020
Feb 7, 2020
Jan 21, 2020
Jan 16, 2020
A securities fraud class action complaint has been filed on behalf of certain investors in PORTOLA PHARMACEUTICALS INC.
TOP
